Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-MP in pulmonary arterial hypertension
NL-OMON29513Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mercaptopurine in pulmonary arterial hypertension (PAH), sponsored by Vrije University Medical Center. Primary endpoint: Change in pulmonary vascular resistance. Started Jul 2017; status: recruiting.
02
Drugs
mercaptopurine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NL-OMON29513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29513.